Abstract
Shipments of a Chinese and Canadian-developed COVID-19 candidate vaccine remain delayed from getting to Canada, more than three months after Health Canada approved them for Phase 1 trials here.
Original language | Canadian English |
---|---|
Publication status | Published - Jan. 1 2020 |
Keywords
- COVID-19
- Vaccination Production
- Canada
Disciplines
- Food and Drug Law
- Health Law and Policy
- Law
- Law and Society
- Science and Technology Law